Our non-invasive medical device uses a microfiltration system that exploits the size of cancer cells, enabling efficient, intact, and fixed capture of circulating tumor cells (CTCs) on slides or in suspension.
Designed to filter up to 6 mL of whole blood (2 x 3 mL), the FCD-SP kit ensures optimal cell recovery under morphologically preserved conditions.
For optimal results, CTC isolation should be performed within 4 hours of collection.
Get the most out of your ScreenCell® CTC isolation test with personalized support and expert guidance every step of the way.
Master ScreenCell® technology with hands-on training sessions.
Let our experts help you characterize circulating tumor cells with precision.
Benefit from personalized protocols adapted to your samples, goals, and research.
Our team is here to support you, from the first contact to the analysis.
You’ve come to the right place!
Fill in the fields below and we’ll take care of the rest.
Follow ScreenCell® on LinkedIn
